A major limitation of current predictive prognostic models in patients with COVID-19 is the heterogeneity of population in terms of disease stage and duration. This study aims at identifying a panel of clinical and laboratory parameters that at day-5 of symptoms onset could predict disease progression in hospitalized patients with COVID-19.
Assessment of COVID-19 progression on day 5 from symptoms onset
Gentilotti, Elisa;Savoldi, Alessia;Compri, Monica;Górska, Anna;De Nardo, Pasquale
;Visentin, Alessandro;Be, Giorgia;Razzaboni, Elisa;Soriolo, Nicola;Girelli, Domenico;Micheletto, Claudio;Mehrabi, Sara;Righi, Elda;Tacconelli, Evelina
2021-01-01
Abstract
A major limitation of current predictive prognostic models in patients with COVID-19 is the heterogeneity of population in terms of disease stage and duration. This study aims at identifying a panel of clinical and laboratory parameters that at day-5 of symptoms onset could predict disease progression in hospitalized patients with COVID-19.
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
